Caplin Point Lab

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE475E01026
  • NSEID: CAPLIPOINT
  • BSEID: 524742
INR
2,368.05
34.8 (1.49%)
BSENSE

Jun 18

BSE+NSE Vol: 45.02 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Granules India
Caplin Point Lab
Natco Pharma
OneSource Speci.
ERIS Lifescience
Concord Biotech
Astrazeneca Phar
Jubilant Pharmo
Pfizer
Cohance Life
Alembic Pharma
Why is Caplin Point Laboratories Ltd ?
1
High Management Efficiency with a high ROE of 19.33%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
The company has declared Positive results for the last 15 consecutive quarters
  • NET SALES(Q) Highest at Rs 600.16 cr
  • PBDIT(Q) Highest at Rs 204.24 cr.
  • PAT(Q) Highest at Rs 170.11 cr.
4
Stock is technically in a Bullish range
  • The technical trend has improved from Sideways on 16-Jun-26
  • Multiple factors for the stock are Bullish like MACD, Bollinger Band, KST and OBV
5
Majority shareholders : Promoters
6
Consistent Returns over the last 3 years
  • Along with generating 13.28% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to Caplin Point Lab should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Caplin Point Lab for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Caplin Point Lab
13.36%
0.39
33.90%
Sensex
-5.16%
-0.39
13.26%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
15.56%
EBIT Growth (5y)
18.73%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.28
Sales to Capital Employed (avg)
0.74
Tax Ratio
19.07%
Dividend Payout Ratio
8.50%
Pledged Shares
0
Institutional Holding
8.29%
ROCE (avg)
32.65%
ROE (avg)
19.33%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
28
Industry P/E
34
Price to Book Value
4.95
EV to EBIT
24.32
EV to EBITDA
22.00
EV to Capital Employed
6.48
EV to Sales
7.65
PEG Ratio
1.41
Dividend Yield
0.30%
ROCE (Latest)
26.63%
ROE (Latest)
17.88%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
NET SALES(Q)

Highest at Rs 600.16 cr

PBDIT(Q)

Highest at Rs 204.24 cr.

PAT(Q)

Highest at Rs 170.11 cr.

PBT LESS OI(Q)

Highest at Rs 185.08 cr.

EPS(Q)

Highest at Rs 22.38

-3What is not working for the Company
ROCE(HY)

Lowest at 22.38%

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.65 times

Loading Valuation Snapshot...
Here's what is working for Caplin Point Lab
Net Sales - Quarterly
Highest at Rs 600.16 cr and Grown
each quarter in the last five quarters
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 204.24 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 170.11 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 185.08 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 185.08 cr has Grown at 22.63%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 22.38
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for Caplin Point Lab
Debtors Turnover Ratio- Half Yearly
Lowest at 2.65 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio